Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects
2005

Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Taylor D D, Gerçel-Taylor C

Primary Institution: University of Louisville School of Medicine

Hypothesis

This investigation examines the composition of tumour-derived ‘exosomes' and their effects on T lymphocytes.

Conclusion

Tumour-derived exosomes can suppress T-cell signalling molecules and induce apoptosis.

Supporting Evidence

  • Exosomes suppressed expression of T-cell activation signalling components, CD3-ζ and JAK 3.
  • Exosomes induced apoptosis in T lymphocytes as measured by DNA fragmentation.
  • Exosomes expressed class I MHC and other tumour-associated antigens.

Takeaway

Cancer cells release tiny bubbles called exosomes that can confuse immune cells, making them less effective at fighting cancer.

Methodology

Membranous materials were isolated from ascites of ovarian cancer patients and evaluated for their effects on T lymphocytes using Western immunoblotting.

Potential Biases

Potential bias due to the specific patient population and the methods of exosome isolation.

Limitations

The study is limited by the small sample size and the specific cancer type examined.

Participant Demographics

Women diagnosed with stage IIIc papillary serous adenocarcinoma of the ovary.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602316

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication